[
    [
        {
            "time": "",
            "orginal_text": "疫苗巨头为何想“杀掉快下蛋的鸡”？董事长回应，71亿隐秘野心曝光",
            "features": {
                "keywords": [
                    "疫苗",
                    "巨头",
                    "董事长",
                    "71亿",
                    "野心"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "疫苗巨头为何想“杀掉快下蛋的鸡”？董事长回应，71亿隐秘野心曝光",
            "scores": {
                "News_content": "疫苗巨头为何想“杀掉快下蛋的鸡”？董事长回应，71亿隐秘野心曝光",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "沃森生物欲卖上海泽润股权背后：HPV疫苗竞争激烈 拟转投mRNA新冠疫苗研发",
            "features": {
                "keywords": [
                    "沃森生物",
                    "HPV疫苗",
                    "mRNA",
                    "新冠疫苗",
                    "竞争"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "沃森生物欲卖上海泽润股权背后：HPV疫苗竞争激烈 拟转投mRNA新冠疫苗研发",
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "【排雷】不出所料！跌停！成交额近百亿元...沃森生物割了谁的韭菜？",
            "features": {
                "keywords": [
                    "排雷",
                    "跌停",
                    "沃森生物",
                    "成交额",
                    "韭菜"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "【排雷】不出所料！跌停！成交额近百亿元...沃森生物割了谁的韭菜？",
            "scores": {
                "News_content": "【排雷】不出所料！跌停！成交额近百亿元...沃森生物割了谁的韭菜？",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "沃森生物71亿隐秘野心：高瓴资本、“泰格系”两度接盘，李云春为何弃泽润如鸡肋？",
            "features": {
                "keywords": [
                    "沃森生物",
                    "71亿",
                    "高瓴资本",
                    "泰格系",
                    "李云春",
                    "泽润"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "沃森生物71亿隐秘野心：高瓴资本、“泰格系”两度接盘，李云春为何弃泽润如鸡肋？",
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "果然跌停！改口不卖是“缓兵之计”？沃森生物人心已失，投资者出逃用脚投票",
            "features": {
                "keywords": [
                    "跌停",
                    "改口",
                    "缓兵之计",
                    "沃森生物",
                    "投资者"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "果然跌停！改口不卖是“缓兵之计”？沃森生物人心已失，投资者出逃用脚投票",
            "scores": {
                "Correlation": 8,
                "Sentiment": 1,
                "Importance": 7,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "沃森生物上演剧情大反转，被质疑“贱卖资产”后改口不卖了丨时间线 资产异常",
            "features": {
                "keywords": [
                    "沃森生物",
                    "贱卖资产",
                    "剧情反转",
                    "质疑",
                    "改口"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "沃森生物上演剧情大反转，被质疑“贱卖资产”后改口不卖了丨时间线 资产异常",
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "被指“杀掉快下蛋的鸡”后，疫苗巨头突然改口，可股价仍大跌17%，123亿市值蒸发！ 连续下跌",
            "features": {
                "keywords": [
                    "疫苗",
                    "巨头",
                    "改口",
                    "股价大跌",
                    "市值蒸发"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "被指“杀掉快下蛋的鸡”后，疫苗巨头突然改口，可股价仍大跌17%，123亿市值蒸发！ 连续下跌",
            "scores": {
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "刚刚，20%跌停！“紧急改口”也挡不住暴跌",
            "features": {
                "keywords": [
                    "跌停",
                    "紧急改口",
                    "暴跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "刚刚，20%跌停！“紧急改口”也挡不住暴跌",
            "scores": {
                "News_content": "刚刚，20%跌停！“紧急改口”也挡不住暴跌",
                "Correlation": 8,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 10,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "21深度｜沃森出售泽润一波三折：收关注函、暂停交易、股票跌停，到底哪种疫苗才是沃森的“金矿”？ 关注函",
            "features": {
                "keywords": [
                    "沃森",
                    "泽润",
                    "关注函",
                    "暂停交易",
                    "股票跌停",
                    "金矿"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "21深度｜沃森出售泽润一波三折：收关注函、暂停交易、股票跌停，到底哪种疫苗才是沃森的“金矿”？ 关注函",
            "scores": {
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "市场大事件丨电话会议变成公开骂战，明星疫苗股大跌140亿",
            "features": {
                "keywords": [
                    "市场大事件",
                    "电话会议",
                    "骂战",
                    "明星疫苗股",
                    "大跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "市场大事件丨电话会议变成公开骂战，明星疫苗股大跌140亿",
            "scores": {
                "Correlation": 8,
                "Sentiment": 1,
                "Importance": 7,
                "Impact": 8,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]